Lineage Cell Therapeutics (LCTX) Goodwill (2019 - 2026)

Lineage Cell Therapeutics' Goodwill history runs 8 years deep, the most recent figure standing at $10.7 million for Q1 2026.

• On a quarterly basis, Goodwill changed 0.0% year-over-year to $10.7 million in Q1 2026; TTM through Mar 2026 was $10.7 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $10.7 million, changed 0.0% from the prior year.
• Goodwill held at $10.7 million in Q1 2026 per LCTX's latest filing, from $10.7 million in the prior quarter.
• Across five years, Goodwill topped out at $10.7 million in Q1 2022 and bottomed at $10.7 million in Q1 2022.
• The 5-year median for Goodwill is $10.7 million (2022), against an average of $10.7 million.
• Biggest YoY gain for Goodwill was 0.0% in 2022; the steepest drop was 0.0% in 2022.
• Year by year, Goodwill stood at $10.7 million in 2022, then changed by 0.0% to $10.7 million in 2023, then changed by 0.0% to $10.7 million in 2024, then changed by 0.0% to $10.7 million in 2025, then changed by 0.0% to $10.7 million in 2026.
• Per Business Quant, the three latest LCTX Goodwill figures stand at $10.7 million (Q1 2026), $10.7 million (Q4 2025), and $10.7 million (Q3 2025).